Profil
Igor A. Sherman is the founder of Alpha Cancer Technologies, Inc. since 2008, serving as President & Chief Executive Officer.
Former positions include Director-Scientific Affairs at YM BioSciences, Inc. and Analyst at JPMorgan Securities LLC from 2005 to 2010.
Education includes an undergraduate degree from the University of Connecticut, conferred in 2003.
Postes actifs de Igor A. Sherman
| Sociétés | Poste | Début |
|---|---|---|
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs | Directeur Général | 01/01/2008 |
Anciens postes connus de Igor A. Sherman
| Sociétés | Poste | Fin |
|---|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides corporate, investment banking, consumer and commercial banking, asset management, payment & security solutions | Analyst-Fixed Income | 01/08/2010 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Directeur Technique/Scientifique/R&D | - |
Formation de Igor A. Sherman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides corporate, investment banking, consumer and commercial banking, asset management, payment & security solutions | Finance |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs | Health Technology |
















